Diagnos Inc.
TSX VENTURE : ADK

Diagnos Inc.

November 26, 2008 10:36 ET

DIAGNOS Announces Grant of Options

BROSSARD, QUEBEC, CANADA--(Marketwire - Nov. 26, 2008) - DIAGNOS inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, announces that, on November 18, 2008, the Board of Directors has approved a grant of 100,000 stock options, to Mr Chris Orchard, Director, under the terms of the share stock option plan of the Corporation approved by the Shareholders in September 2008.

The exercise price has been established at $0.19 per share. The expiry date where these options can be exercised has been fixed to November 17, 2013.

DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, mathematics, as well as remote sensing and image interpretation. The Corporation's objective is to develop a royalty stream by significantly enhancing and participating in the exploration success rate of mining and oil and gas companies. For further information, please visit our website at www.diagnos.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information